4//SEC Filing
Dunlap Ryan 4
Accession 0001104659-24-112756
CIK 0001175680other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 9:46 PM ET
Size
13.6 KB
Accession
0001104659-24-112756
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Dunlap Ryan
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2024-10-28+800,000→ 800,000 totalExercise: $0.13Exp: 2034-10-28→ Common Stock (800,000 underlying)
Footnotes (2)
- [F1]This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.
- [F2]266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.
Issuer
CytoDyn Inc.
CIK 0001175680
Entity typeother
Related Parties
1- filerCIK 0001554742
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 9:46 PM ET
- Size
- 13.6 KB